Education
About Us
Working with TipRanks
Follow Us
SNDL (SNDL)
NASDAQ:SNDL
SNDL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.15 - $2.40
Previous CloseN/A
Volume1.04M
Average Volume (3M)2.42M
Market Cap
$424.57M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Nov 17, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding257,315,830
10 Day Avg. Volume2,985,329
30 Day Avg. Volume2,415,384
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.50Price Target Upside-9.09% Downside
Rating ConsensusHold
Number of Analyst Covering0
SNDL News
SNDL FAQ
What was SNDL’s price range in the past 12 months?
SNDL lowest stock price was $1.15 and its highest was $2.40 in the past 12 months.
What is SNDL’s market cap?
SNDL’s market cap is $424.57M.
When is SNDL’s upcoming earnings report date?
SNDL’s upcoming earnings report date is Nov 17, 2025 which is in 106 days.
How were SNDL’s earnings last quarter?
SNDL released its earnings results on Jul 31, 2025. The company reported $0.007 earnings per share for the quarter, beating the consensus estimate of -$0.036 by $0.043.
Is SNDL overvalued?
According to Wall Street analysts SNDL’s price is currently Overvalued.
Does SNDL pay dividends?
SNDL does not currently pay dividends.
What is SNDL’s EPS estimate?
SNDL’s EPS estimate is >-0.01.
How many shares outstanding does SNDL have?
SNDL has 257,315,830 shares outstanding.
What happened to SNDL’s price movement after its last earnings report?
SNDL reported an EPS of $0.007 in its last earnings report, beating expectations of -$0.036. Following the earnings report the stock price went up 19.444%.
Which hedge fund is a major shareholder of SNDL?
Currently, no hedge funds are holding shares in SNDL
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.50 (-9.09% Downside)
$1.50 (-9.09% Downside)
Blogger Sentiment
Bullish
SNDL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 39.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $14.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.33%
12-Months-Change
Fundamentals
Return on Equity
-8.30%
Trailing 12-Months
Asset Growth
-12.01%
Trailing 12-Months
Company Description
SNDL
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
SNDL Company Deck
SNDL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including first-time positive operating income, strong growth in the cannabis segment, and successful international expansion. Despite these positive developments, challenges such as negative free cash flow and ongoing issues in the U.S. market were noted. Overall, the positive highlights outweigh the lowlights, indicating a strong quarter and a promising outlook.Read More>Technical Analysis
cbdMD
―
Tilray
―
Cosmos Holdings
―
Flora Growth
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
4.86% Insiders
0.15% Mutual Funds
0.08% Other Institutional Investors
90.48% Public Companies and
Individual Investors